Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Urologic Neoplasms 2Stomach Neoplasms 2Brain Neoplasms 2beta-Thalassemia 1Urinary Bladder Neoplasms 1Supratentorial Brain Tumor Surgery 1Strabismus 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Post-operative Residual Curarization 1Obesity 1Neuromuscular Blockade 1Neoplasms 1Myasthenia Gravis 1Hepatoblastoma 1Endobronchial Metastases 1Emergence Delirium 1Delayed Emergence from Anesthesia 1

Interventions

Sugammadex 1Neostigmine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Supratentorial Brain Tumor Surgery × Sugammadex × Clear all
NCT02944175 2018-10-19

Cerebral Oxygenation and Metabolism After Reversal Of Rocuronium: Comparison Between Sugammadex Versus Neostigmine

Mansoura University

Phase NA Unknown
40 enrolled

Supratentorial Brain Tumor Surgery

Data powered by HemOnc (CC BY 4.0) Colophon âš¡